Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA advisory letters on promotions up 123% in 1995: DTC advice predominates; FY 1997 budget request.

Executive Summary

FDA AD DIVISION ADVISORY LETTERS MORE THAN DOUBLED IN FY 1995, the agency reports in its fiscal 1997 budget justification document. Actions by the Division of Drug Marketing, Advertising & Communications during fiscal 1995 included the issuance of 624 advisory letters and 46 advisory conferences, FDA said. The number of advisory conferences increased 31%, the agency observed. These advance consultations "have resulted in cost avoidances for industry and the American consumer because fewer corrective actions were necessary," FDA maintained.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027865

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel